Payer Management

Every year, billions of retail prescriptions are filled in the U.S., and each prescription could be eligible for a rebate based on payer contracts.

Private Payer Reimbursing Doctor For Telemedicine

Accurate, timely rebate and fee validation, calculation, and settlement are crucial to maintaining profitability.
Innovative and value-based rebates create operationally complex agreements that are difficult to execute.
Manual processes and spreadsheet-based tools hamper efforts to accurately calculate rebates on a timely basis.

Benefits of Model N Payer Management

Optimize revenue and ensure compliance with your payer agreements

Increased visibility

Gain visibility and control into your payer revenue management process to ensure the right payers are getting the right discounts.

Improved margins

Maximize revenue by reducing rebate overpayments and rejecting invalid claims.

Reduced effort

Rely on a single platform for managing contracts, pricing, formulary placements, and plans.

Trusted by leading pharma innovators

Maximize revenue with a comprehensive, cloud-based solution

Payer Management supports the simplest to the most complex rebate programs with health plans and pharmacy benefit managers.

Accurate calculations

Automatically calculate formulary-based rebates, price protection, admin fees, and various other rebate types.

Strategy designer

Leverage prescription, sales, and clinical data to build and implement pricing and rebate strategies.

Single repository

Reduce manual effort by keeping all structured contract documentation in a single location.

ERP integration

Facilitate prompt payments and avoid costly late fees.

Contract template library

Improve governance and reduce risk with preapproved contract templates, approval workflows, and version tracking.

Streamline and automate revenue processes from end to end

The industry’s only end-to-end payer management solution, Payer Management is a core component of the Model N revenue optimization platform, purpose-built to help life sciences companies drive profit, not problems.